Schlagwort: crypto markets

• Bio Protocol funds $80K brain health trial, earning CLAW royalty tokens.
• Staked BIO tokens rise to 125M, tightening supply and boosting demand.
• Harmonic chart pattern signals a possible BIO price rally toward $0.1787.

The Bio Protocol (BIO) token has regained strong momentum after a sharp pullback earlier this month, climbing to a six-month high of $0.1514 before settling near $0.138.

The recovery follows a string of bullish catalysts, ranging from real-world biotech partnerships to a surge in staking activity, while traders are now watching technical signals that hint at further upside.

BIO price recovery sparks fresh momentum

After dropping to $0.0962 during the recent correction, BIO has staged an impressive rebound of more than 50% in a matter of days.

The strong recovery comes at a time when the broader crypto market has been under selling pressure, yet Bio Protocol has managed to move against the trend.

At press time, the token was trading nearly 100% higher on the month, underscoring its growing resilience.

Trading activity has also intensified. Daily volumes have spiked by more than 700% last week, crossing $440 million as new investors piled in.

This sharp increase in liquidity has strengthened confidence that BIO’s market depth is improving, making it more attractive for both retail and institutional traders.

Clinical trial funding lifts sentiment

One of the strongest drivers of BIO’s price rally has been the announcement of its first major biotech initiative.

Through its partner Cerebrum DAO, the Bio Protocol community approved $80,000 in funding for a Phase 2 human clinical trial of Percepta, a supplement targeting memory loss and neurodegeneration.

Big week in the Biosphere 🧪

• Launched Bio Markets w/ real-time DeSci analytics & BioAgent trading coming
• 125M+ $BIO staked + 1M BioXP Boost
• Funding human trial for Percepta $CLAW
• Molecule V2 DeSci equity
• $BeeARD psilocybin derivative

Read the full weekly update: https://t.co/l5lH2Utcjo

— Bio Protocol (@BioProtocol) August 17, 2025

The deal not only gives Bio Protocol direct exposure to real-world biotech outcomes but also provides it with CLAW tokens.

These tokens are tied to royalties from Percepta sales, creating a potential revenue-sharing model that sets BIO apart from other speculative altcoins.

Investors see this as a sign that the project is delivering on its promise to link decentralised finance with biotech innovation.

BIO token staking reduces supply pressure

Another factor supporting BIO’s price is the steady growth in token staking.

The amount of staked BIO tokens has climbed to 125 million, representing about 3.5% of the circulating supply.

This is a significant jump from 25 million staked tokens earlier in August.

By staking, holders earn BioXP, which provides access to new ecosystem assets such as CLAW. More importantly, staking reduces the liquid supply on exchanges.

As a result, when demand rises, the price impact is magnified. Traders are already drawing comparisons to earlier DeFi tokens where similar dynamics sparked explosive rallies.

Technical setup points to higher targets

From a technical perspective, BIO has cleared several key resistance levels. It moved above the 7-day simple moving average at $0.116 and broke through the 23.6% Fibonacci retracement at $0.128.

The next resistance sits near $0.145, with momentum indicators suggesting strong buying pressure despite a relative strength index that hovers near overbought territory.

Adding to this outlook, analysts have identified a harmonic ABCD pattern unfolding on the 4-hour chart.

The harmonic ABCD pattern began with a rally from $0.0559 to $0.0956 before retracing and launching into a bullish CD-leg.

The extension of this structure projects an upside target near $0.1800, which traders are closely monitoring as the next profit-taking zone.

Bio Protocol price outlook remains cautiously bullish

While the harmonic setup points to further upside, traders remain alert to the possibility of consolidation.

A failure to hold above the 50-period moving average, currently near $0.1159, could open the door to short-term corrections.

Still, the combination of real-world utility, staking-driven scarcity, and a favourable technical structure has left sentiment firmly bullish.

Bio Protocol’s six-month high marks an important milestone for a token launched less than a year ago.

But whether it can sustain this rally will depend on both the outcome of the Percepta trial and the broader adoption of decentralised science models.

The post Bio Protocol hits 6-month high as harmonic pattern signals further upside appeared first on CoinJournal.

• Bio Protocol price rose more than 50% as bulls defied broader market selling to hit $1.46
• Despite overall sell-off pressure, BIO price is up double-digits in 24 hours as volume spikes 720%.
• BIO has benefited from key network developments, including staking and partnerships.

The price of Bio Protocol (BIO) shrugged off a broader crypto downturn to lead 24-hour gainers on Monday.

With the project that’s targeting the decentralized science (DeSci) ecosystem hitting key milestones recently, buyers have upped the ante by pushing BIO higher.

BIO price surges nearly 50% to lead top gainers

The Bio Protocol (BIO) price saw a significant surge as top altcoins struggled amid profit taking.

With Bitcoin shedding gains to below $116k and Ethereum dipping to $4,200, the BIO token climbed nearly 50% to lead the top gainers.

Per CoinMarketCap, this put the decentralized science project among the 500 largest cryptocurrencies by market capitalization.

Notably, Bio Protocol traded up from lows of $0.10 and topped $0.15.

The uptick meant BIO defied overall declines across the market, with gains coming as its 24-hour volume spiked 720% to over $393 million.

Although BIO remains double-digits up with over 21% upside in the past 24 hours, it has dropped from the $0.15 high. This shows the overall market weakness as sellers drive it to around $0.12.

Bio Protocol has hit key network milestones

Bio Protocol has gained amid significant network milestones in the past week.

As the DeSci economy picks up, the Bio Protocol team has positioned the project for greater traction with the launch of Bio Markets.

The goal is a platform that brings real-time insights into projects within the Bio Protocol ecosystem.

Markets bring growth trends and in-app trading for BioDAOs, and Bio plans to expand trading capabilities to IP-Tokens and new BioAgents.

Staking activity has also soared, with over 125 million BIO tokens staked, up to 3.5% of the circulating supply.

As the Bio team recently noted, staking generates BioXP, a key component for participating in upcoming Ignition Sales.

Unveiling of Yapping BioXP, also set to go live in the app this week, includes a boost campaign for BioAgents, further incentivizing community engagement.

What does it mean for BIO price?

Bio Protocol also hit a major milestone with CLAW, Percepta’s IP-Token.

Meanwhile, Molecule’s development of its v2 protocol targets the bridging of traditional corporate structures with DeSci.

Listing on Coinbase, the top U.S.-based crypto exchange, allows for further institutional adoption.

“From Bio V2’s launch and 100M+ BIO staked, to Coinbase listing $BIO and VitaDAO advancing longevity trials, the past month marked key steps in AI-driven science and DeSci adoption,” Bio Protocol recently posted.

Achievement of these milestones could help bolster the price of BIO.

The post Bio Protocol defies crypto downturn with a 720% surge in volume appeared first on CoinJournal.

• Dogecoin price is down 5% in 24 hours to hover near $0.22.
• The DOGE price movement is similar to that of most altcoins that are seeing profit-taking.
• Analysts are bullish on DOGE as whale accumulation continues.

Dogecoin (DOGE) has experienced a slight decline in the past 24 hours, dropping to lows of $0.22 amid a technical pattern breakdown.

The top memecoin’s price movement mirrors the broader cryptocurrency market’s price action in the past few days.

Bitcoin dipping to below $117k and Ethereum paring gains from near its all-time high buoyed bears.

While profit taking is driving current downside pressure, analysts are bullish on Dogecoin amid whale accumulation, spot ETF anticipation and long-term crypto trajectory.

Dogecoin price dips amid profit-taking

The latest decline in Dogecoin’s price has seen it breach a critical support level, driven by profit-taking and overall investor uncertainty.

DOGE reached highs of $0.24 as bulls attempted a breakout after an uptick from lows of $0.21 in the past week.

But as investors, wary of macroeconomic uncertainties, took profits, the top memecoin’s price dropped from above $0.24.

The move aligns with a rising wedge breakdown, which has accelerated the downturn to the support level around $0.22.

Bulls could face more pressure towards the psychological $0.20 area.

Despite the bearish price action, on-chain data reveals large investors are buying the dip.

Whale wallets, which have historically scooped DOGE amid price dips, have added to their portfolios.

Aggressive buying by whales has seen such wallets approach 100 billion DOGE in the past few weeks, the trend picking up momentum in the latest dip.

This is an outlook that could help DOGE price higher.

However, the memecoin is likely to hit the rocks if the Dogecoin network suffers a setback from a potential 51% attack, which could undermine network integrity if executed.

DOGE price prediction

The technical outlook for Dogecoin remains largely bullish, despite its notable dip in the past 24 hours.

However, losses have compounded to more than 12% in the past month, and the breakdown below $0.23, a critical threshold, has opened the door to further downside risks.

DOGE has, on multiple occasions, failed to convincingly break above the $0.24 mark.

With this supply wall helping to repeatedly cap Dogecoin’s upward potential, bears have tried to take advantage.

The breakdown of the rising wedge means the next target could be $0.20 or below.

Broader market conditions deteriorating will embolden bears.

Conversely, bullish signs that could help bulls include the recently formed golden cross and whale activity.

The technical indicators on the daily chart also show that DOGE is above the middle line of the Bollinger Bands, and the MACD is also holding onto the bullish picture.

Daily RSI is suggesting extended pressure, though.

If buyers reclaim the $0.23 level, a retest of $0.40 and $0.65 is possible. Analysts say a breakout to $1 in 2025 is still possible.

The post Dogecoin price falls to $0.22 after pattern breakdown appeared first on CoinJournal.

• Crypto leverage surges 27% to $53.1 billion, its highest since early 2022.
• A recent Bitcoin dip triggered a massive $1 billion liquidation of long bets.
• Stress points are emerging in DeFi lending and key dollar markets.

A ghost from bull markets past is haunting the cryptocurrency landscape: massive, unrestrained leverage.

A speculative fever is once again gripping traders, pushing borrowing to levels not seen since the last cycle’s peak.

But as a brutal billion-dollar liquidation event last Thursday proved, this double-edged sword can carve out devastating losses just as quickly as it creates gains.

The scale of this renewed appetite for risk is staggering. According to Galaxy Research’s Q2 State of Crypto Leverage report, the market for crypto-collateralized loans swelled by an incredible 27% last quarter, reaching a total of $53.1 billion.

Powered by record demand in DeFi and a return to risk-on sentiment, this represents the highest level of leverage in the system since the precarious heights of early 2022. This mountain of debt created the perfect backdrop for the violent shakeout that was to come.

The inevitable spark: a billion-dollar wipeout

When Bitcoin retreated from its high of $124,000 to as low as 118,000 last week, the over leveraged system snapped.

The price drop triggered a cascade of liquidations across crypto derivatives, wiping out more than 1 billion in long positions—the largest such event since early August.

While many analysts were quick to frame the purge as healthy profit-taking, it served as a stark and painful reminder of just how fragile the market becomes when speculative bets build this rapidly.

Cracks in the foundation

According to Galaxy’s analysts, this fragility is not just theoretical; the stress points are already visible and spreading. In July, a wave of withdrawals on the lending platform Aave caused ETH borrowing rates to spike above Ethereum’s staking yields.

This seemingly small shift broke the economics of the wildly popular “looping” trade, where investors use staked ETH as collateral to borrow more ETH to stake again.

The sudden unwinding of these positions triggered a frantic rush for the exits, overwhelming the network and sending the Ethereum Beacon Chain’s exit queue to a record-breaking 13 days.

The trouble doesn’t end there. Galaxy has also flagged a growing and worrying disconnect in the dollar markets. Since July, the borrowing costs for USDC in the over-the-counter (OTC) market have been climbing, even as rates on DeFi platforms remain flat.

This has widened the spread between the two to its highest point since late 2024, suggesting off-chain demand for dollars is critically outpacing on-chain liquidity. It is a dangerous mismatch that could dramatically amplify volatility if market conditions tighten.

Beneath the deceptive calm of a market waiting for Fed Chair Jerome Powell’s next move, a different story is unfolding.

While institutional demand and ETF inflows paint a bullish picture, the system’s plumbing is showing more and more points of stress.

Last Thursday’s billion-dollar flush was not an anomaly; it was a warning that the return of leverage is a fire that can warm the market or burn it to the ground.

The post Crypto leverage surges 27% to $53.1 billion, hitting highest level since early 2022 appeared first on CoinJournal.